Articles |
From the Department of Etiology and Pathophysiology, National Cardiovascular Center Research Institute (T.M., Y. Miyake, M.H.-S., T.Y., A.Y.); Institute for Protein Research, Osaka University (S.T.); Department of Internal Medicine, National Cardiovascular Center Hospital (M.T.); Department of Internal Medicine, Izumisano City Hospital (B-i.K.); Department of Pediatrics, Kitasato University Hospital (Y.H.); and Second Department of Internal Medicine, Osaka University Medical School (T.F., Y. Matsuzawa), Osaka, Japan.
Correspondence to Takao Maruyama, Department of Etiology and Pathophysiology, National Cardiovascular Center Research Institute, 5-7-1, Fujishiro-dai, Suita, Osaka 565, Japan.
Abstract Familial
hypercholesterolemia (FH) is a common genetic
disorder caused by mutations of the LDL-receptor gene. In the
present study, we investigated four Japanese FH homozygotes and
identified five point mutations: a splice site mutation in intron 12
(the 1845+2 T
C mutation), a missense mutation in exon 7 (the C317S
mutation), a nonsense mutation in exon 17 (the K790X mutation), a
missense mutation in exon 14 (the P664L mutation), and a missense
mutation in exon 4 (the E119K mutation). We developed simple methods
for detecting these mutations. When we examined the presence of these
mutations in 24 unrelated FH homozygotes, the 1845+2 T
C mutation was
found in 7 of them, and the other four mutations were unique for each
proband. We also screened 120 unrelated FH heterozygotes for these
mutations and found that the frequencies of the 1845+2 T
C, C317S,
K790X, P664L, and E119K mutations were 13.3% (16/120), 6.7% (8/120),
6.7% (8/120), 3.3% (4/120), and 1.7% (2/120), respectively. These
mutations were found in more than 30% of unrelated Japanese FH
patients. By using the detection methods developed in this study, the
diagnosis of more than 30% of the genetic bases of Japanese FH
heterozygotes is expected.
Key Words: LDL receptor common mutation Japanese familial hypercholesterolemia
This article has been cited by other articles:
![]() |
M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review Am. J. Epidemiol., September 1, 2004; 160(5): 407 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Chang, J.-P. Pan, D.-Y. Tai, A.-C. Huang, P.-H. Li, H.-L. Ho, H.-L. Hsieh, S.-C. Chou, W.-L. Lin, E. Lo, et al. Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese J. Lipid Res., October 1, 2003; 44(10): 1850 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Tai, E. S.C. Koay, E. Chan, T. J. Seng, L. M. Loh, S. K. Sethi, and C. E. Tan Compound Heterozygous Familial Hypercholesterolemia and Familial Defective Apolipoprotein B-100 Produce Exaggerated Hypercholesterolemia Clin. Chem., March 1, 2001; 47(3): 438 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bertolini, A. Cantafora, M. Averna, C. Cortese, C. Motti, S. Martini, G. Pes, A. Postiglione, C. Stefanutti, I. Blotta, et al. Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype Arterioscler Thromb Vasc Biol, September 1, 2000; 20 (9): e41 - e52. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. von Kodolitsch, R. E. Pyeritz, and P. K. Rogan Splice-Site Mutations in Atherosclerosis Candidate Genes : Relating Individual Information to Phenotype Circulation, August 17, 1999; 100(7): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-T. Mak, C.-P. Pang, B. Tomlinson, J. Zhang, Y.-S. Chan, T. W. L. Mak, and J. R. L. Masarei Mutations in the Low-Density Lipoprotein Receptor Gene in Chinese Familial Hypercholesterolemia Patients Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1600 - 1605. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |